X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4100) 4100
Publication (152) 152
Book Review (37) 37
Book Chapter (8) 8
Magazine Article (5) 5
Conference Proceeding (4) 4
Book / eBook (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3624) 3624
urokinase-type plasminogen activator - therapeutic use (2743) 2743
male (1875) 1875
female (1806) 1806
middle aged (1382) 1382
aged (1086) 1086
adult (1021) 1021
thrombolytic therapy (876) 876
animals (846) 846
urokinase-type plasminogen activator - administration & dosage (833) 833
fibrinolytic agents - therapeutic use (784) 784
urokinase (743) 743
index medicus (694) 694
streptokinase - therapeutic use (631) 631
urokinase-type plasminogen activator - metabolism (564) 564
plasminogen activators - therapeutic use (526) 526
thrombosis - drug therapy (484) 484
tissue plasminogen activator - therapeutic use (480) 480
treatment outcome (478) 478
myocardial infarction - drug therapy (451) 451
heparin - therapeutic use (436) 436
time factors (421) 421
surgery (362) 362
peripheral vascular disease (360) 360
thrombolytic therapy - methods (356) 356
thrombolysis (342) 342
pulmonary embolism - drug therapy (334) 334
mice (327) 327
oncology (322) 322
aged, 80 and over (297) 297
fibrinolysis (297) 297
urokinase-type plasminogen activator - genetics (287) 287
therapy (282) 282
retrospective studies (267) 267
acute disease (264) 264
plasminogen-activator (249) 249
fibrinolytic agents - administration & dosage (248) 248
urokinase-type plasminogen activator - adverse effects (246) 246
follow-up studies (239) 239
cardiac & cardiovascular systems (228) 228
thrombosis (220) 220
expression (219) 219
hematology (212) 212
metastasis (212) 212
adolescent (211) 211
thrombophlebitis - drug therapy (208) 208
clinical neurology (202) 202
prognosis (197) 197
infusions, intra-arterial (195) 195
recombinant proteins - therapeutic use (195) 195
radiology, nuclear medicine & medical imaging (194) 194
cell line, tumor (193) 193
combined modality therapy (190) 190
drug therapy, combination (187) 187
cancer (186) 186
radiography (183) 183
urokinase-type plasminogen activator - pharmacology (183) 183
anticoagulants - therapeutic use (180) 180
streptokinase (179) 179
recurrence (178) 178
fibrinolysis - drug effects (173) 173
thrombosis - etiology (170) 170
urokinase-type plasminogen activator - antagonists & inhibitors (166) 166
endopeptidases - therapeutic use (164) 164
plasminogen activators - administration & dosage (163) 163
prospective studies (163) 163
disease models, animal (159) 159
rats (158) 158
care and treatment (156) 156
child (156) 156
arterial occlusive diseases - drug therapy (152) 152
invasion (150) 150
pharmacology & pharmacy (146) 146
dose-response relationship, drug (143) 143
coronary angiography (141) 141
health aspects (141) 141
leg - blood supply (141) 141
infusions, intravenous (140) 140
biochemistry & molecular biology (139) 139
analysis (138) 138
fibrinolytic agents - adverse effects (138) 138
thrombolytic therapy - adverse effects (135) 135
management (133) 133
tomography, x-ray computed (131) 131
medicine & public health (130) 130
research (130) 130
streptokinase - administration & dosage (130) 130
angiography (124) 124
angioplasty, balloon (123) 123
breast cancer (118) 118
dogs (118) 118
medicine, general & internal (118) 118
rabbits (118) 118
urokinase-type plasminogen activator (118) 118
cell biology (117) 117
risk factors (117) 117
neoplasm invasiveness (116) 116
plasminogen activator inhibitor 1 - metabolism (116) 116
tissue plasminogen activator - administration & dosage (116) 116
proteins (115) 115
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3332) 3332
German (176) 176
Japanese (170) 170
French (147) 147
Chinese (110) 110
Italian (59) 59
Spanish (44) 44
Russian (35) 35
Polish (11) 11
Hungarian (7) 7
Dutch (5) 5
Ukrainian (4) 4
Czech (3) 3
Hebrew (3) 3
Romanian (2) 2
Portuguese (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 04/2016, Volume 227, pp. 45 - 57
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 1, pp. 11 - 20
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2001, Volume 93, Issue 12, pp. 913- - 9120
Journal Article
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 12, Issue 12, p. CD001099
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 01/2014, Volume 37, Issue 1, pp. 43 - 50
Background: The use of thrombolytics is frequently considered in patients with cerebral venous and dural sinus thrombosis (CVT) who deteriorate despite... 
Original Paper | Urokinase | Recombinant tissue plasminogen activator | Intravenous thrombolysis | Dural sinus thrombosis | Cerebral venous thrombosis | THERAPY | PLASMINOGEN-ACTIVATOR | PERIPHERAL VASCULAR DISEASE | OF-THE-LITERATURE | VEIN | HEPARIN | CLINICAL NEUROLOGY | Recombinant Proteins - therapeutic use | Intracranial Thrombosis - complications | Urokinase-Type Plasminogen Activator - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Male | Thrombophilia - epidemiology | Thrombophilia - complications | Tissue Plasminogen Activator - adverse effects | Young Adult | Fibrinolytic Agents - adverse effects | Child | Intracranial Hypertension - etiology | Cerebral Hemorrhage - etiology | Cerebral Hemorrhage - chemically induced | Streptokinase - adverse effects | Disease Susceptibility | Venous Thrombosis - drug therapy | Tissue Plasminogen Activator - administration & dosage | Sinus Thrombosis, Intracranial - mortality | Streptokinase - therapeutic use | Brain Damage, Chronic - etiology | Intracranial Thrombosis - mortality | Thrombolytic Therapy | Adolescent | Brain Damage, Chronic - epidemiology | Coma - etiology | Urokinase-Type Plasminogen Activator - adverse effects | Infant | Tissue Plasminogen Activator - therapeutic use | Recombinant Proteins - adverse effects | Venous Thrombosis - complications | Activities of Daily Living | Streptokinase - administration & dosage | Fibrinolytic Agents - therapeutic use | Adult | Female | Intracranial Thrombosis - drug therapy | Urokinase-Type Plasminogen Activator - administration & dosage | Venous Thrombosis - mortality | Cerebral Hemorrhage - mortality | Treatment Outcome | Cerebral Veins | Recombinant Proteins - administration & dosage | Aged | Fibrinolytic Agents - administration & dosage | Infusions, Intravenous | Sinus Thrombosis, Intracranial - drug therapy | Sinus Thrombosis, Intracranial - complications
Journal Article
Journal Article